Tag: publicly traded company
Swiss drugmaker Novartis to buy Avidity Biosciences for $12 billion
Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for...
Novartis to acquire Avidity Biosciences for about $12 billion
By Padmanabhan Ananthan and Angela Christy M (Reuters) -Swiss drugmaker Novartis on Sunday said...

